Home
>
National Drug Code (NDC)
>
METHOTREXATE
METHOTREXATE - 0703-3675-01 - (methotrexate sodium)
Drug Information of METHOTREXATE
| Product NDC: | 0703-3675 |
| Proprietary Name: | METHOTREXATE |
| Non Proprietary Name: | methotrexate sodium |
| Active Ingredient(s): | 25 mg/mL & nbsp; methotrexate sodium |
| Administration Route(s): | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of METHOTREXATE
| Product NDC: | 0703-3675 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040853 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120801 |
Package Information of METHOTREXATE
| Package NDC: | 0703-3675-01 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-3675-01) > 10 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of METHOTREXATE
| NDC Code | 0703-3675-01 |
| Proprietary Name | METHOTREXATE |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-3675-01) > 10 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0703-3675 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | methotrexate sodium |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Start Marketing Date | 20120801 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | METHOTREXATE SODIUM |
| Strength Number | 25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
